Research
Drug Cartels In The USA
Could manufacturer drug cartels lead to higher generic drug prices?
You can read our full research here:
Underwriting in the US Bond Markets – Why the Status Quo Poses Risks to Competition
Paul joined Fideres after completing a BSc in Economic History at the London School of Economics and Political Science. At LSE, Paul was a Trustee of the Student Union and President of the Music Society, having previously performed with two national choirs in the US. At Fideres, Paul leads our discrimination litigation practice, analysing cases of algorithmic and indirect discrimination, in addition to his work in the Competition team, where he is a project manager. On the Competition team, Paul’s work spans financial markets, with his research on bond market manipulation published by the ABA, digital markets, and industrial organisation.
Could manufacturer drug cartels lead to higher generic drug prices?
Fideres Study Finds Ofcom May Have Allowed Voice-Only Landline Providers to Overcharge Elderly Consumers.
Are UK Water Companies Breaching Competition Law?
London: +44 20 3397 5160
New York: +1 646 992 8510
Rome: +39 06 8587 0405
Frankfurt: +49 61 7491 63000
Johannesburg: +27 11 568 9611
Madrid: +34 919 494 330